Summary: Berra Yazar-Klosinski, Ph.D., of MAPS and MAPS Public Benefit Corporation (MAPS PBC) joins Nick Jikomes, Ph.D., on the Good Chemistry podcast to discuss how and why MDMA-assisted therapy is utilized in the treatment of PTSD.
“We think of MDMA as a non-specific amplifier of whatever feelings and experiences are there,” explains Dr. Yazar-Klosinski. “If somebody is experiencing mental health challenges, those challenges come to the forefront when they’re under the influence [of MDMA].” Listen to the episode in full: maps.org/20210615b
Originally appearing here.
